Is salicylic acid safe during pregnancy?

The verdict

Yes, at the concentrations found in ordinary skincare. A salicylic acid cleanser, toner or spot treatment at 2% or below, used on the face, is treated as acceptable in pregnancy by the bodies that publish on the subject.

The EU sets the hard numbers: salicylic acid is permitted at up to 3.0% in rinse-off hair products, 2.0% in most other products, and just 0.5% in body lotion. Almost every high-street BHA product is formulated at 0.5% to 2%, inside that envelope by design.

That 0.5% body lotion cap is the most useful figure here, because it is the regulator's own version of the "don't use it over large areas" advice - a fourfold reduction applied precisely where the treated surface area is large.

What to skip: salon chemical peels, which run at 20% to 30%. And note that the two American bodies who publish on this do not agree with each other.

Why there is a question at all

Salicylic acid is a beta hydroxy acid, chemically related to acetylsalicylic acid - aspirin. That relationship is the entire source of the concern.

The concern attached to salicylates in pregnancy comes from oral, systemic, therapeutic doses. High-dose oral salicylate late in pregnancy affects the fetal circulation, specifically the ductus arteriosus, which is meant to stay open until birth. That is why oral non-steroidal anti-inflammatory drugs carry third-trimester restrictions.

It is also a medication question, not a cosmetic one. Oral aspirin and other NSAIDs sit outside what this site covers - that conversation belongs with your midwife or obstetrician, particularly because low-dose aspirin is deliberately prescribed in some pregnancies.

The cosmetic question is whether a 2% wash rinsed off a face delivers a systemic salicylate dose in the same universe. It does not, and this has been measured. In a crossover study, nine people had a 30% salicylic acid peel applied to the face for five minutes, and separately took 650mg of oral aspirin. Peak plasma salicylate was 0.81 micrograms per millilitre from the peel against 56.4 from the aspirin - about seventy-fold lower. Therapeutic aspirin levels sit at 150 to 300 micrograms per millilitre. The authors noted that plasma levels from that 30% peel were similar to a 2% leave-on product on the same area.

Absorption does rise with concentration, occlusion, damaged skin and above all the area treated. Every documented case of topical salicylate poisoning in the literature involves 10% to 40% keratolytic ointments on diseased skin over 40% to 75% of the body for days or weeks - psoriasis and ichthyosis treatment, not face wash.

The scary classification, explained

Search the regulatory databases and you will find salicylic acid classified in EU law as Reproductive Toxicity category 2, with the hazard phrase "suspected of damaging the unborn child". That is real, and worth understanding rather than being frightened by.

The classification reflects intrinsic hazard established in high-dose animal feeding studies, not exposure from cosmetics. The EU's scientific committee accepted the classification, agreed salicylic acid is a developmental toxicant and noted it can cross the placenta - then permitted cosmetic use anyway, because exposure at cosmetic concentrations falls far below the effect level. It also recorded that the animal picture varies by species, being strong in rats, lower in monkeys and practically non-existent in rabbits, and that the human data are inconclusive. Its remaining concern is children aged three to ten, not pregnancy.

How much is too much

• Cosmetic cleansers, toners and serums: typically 0.5% to 2%. In the US this is also the exact range set by the over-the-counter acne drug monograph, which permits salicylic acid at 0.5 to 2 percent.
• EU and UK regulatory caps: 3.0% in rinse-off hair products, 2.0% in most other products, and 0.5% in body lotion, eye shadow, mascara, eyeliner, lipstick and roll-on deodorant, under Annex III of the Cosmetics Regulation as amended in 2019. The same entry bars use in preparations for children under three, in products that could be inhaled, and in oral products.
• Above 2%: the AAD's position is that higher-strength salicylic acid should be discussed with a dermatologist and its use limited in pregnancy.
• Chemical peels: 20% to 30%. The US Cosmetic Ingredient Review panel modelled exactly this and calculated margins of safety of 370 and 432 for a 30% peel, and 177 for combined daily body lotion, face cream and hand cream - concluding these margins ensure cosmetic exposure would not result in reproductive or developmental toxicity.
• Surface area: face only is a very different exposure from face, chest, back and shoulders daily - which is what the EU's 0.5% body lotion cap encodes.

A working rule: one 2%-or-below product, on the face, once or twice a day, is well within what any published guidance contemplates.

What to use instead, if you would rather not

Azelaic acid is the ingredient dermatologists most often move pregnant patients to for acne, and it appears on ACOG's usable list alongside topical benzoyl peroxide and glycolic acid, and on the AAD's list alongside vitamin C, hyaluronic acid and niacinamide. Retinoids are the category to avoid outright.

If you have already used it

Nothing follows. Routine use of a low-concentration salicylic acid product is not an exposure event, there is no test, and no authority describes any monitoring or follow-up. If you have had a high-strength chemical peel, that is also not an emergency, and there is no published case series linking cosmetic salicylic acid peels to fetal harm. Postpone further peels and mention it at your next antenatal appointment if you want it recorded.

The useful thing to do is read the labels on everything in your routine at once. Acne products stack - a salicylic cleanser, toner and spot treatment used together deliver considerably more than any one of them.

Where guidance differs

The interesting split here is not between countries. It is between two American bodies, and between two legal systems that cannot agree what kind of product this is.

ACOG endorses it without qualification. Its guidance lists over-the-counter products that can be used during pregnancy, and topical salicylic acid is on that list, alongside topical benzoyl peroxide, azelaic acid and glycolic acid. No concentration cap, no body-area limit, no trimester restriction.

The AAD hedges. It places salicylic acid above 2% in its limit-and-discuss category rather than its avoid category. Its acne page separately calls salicylic acid generally considered safe when used for a limited time. Two US professional bodies, same ingredient, different postures - and the AAD is not entirely consistent with itself.

The EU is the only body with numbers. Its 3.0%, 2.0% and 0.5% caps bind manufacturers, not pregnant users, and there is no pregnancy provision for salicylic acid anywhere in the Cosmetics Regulation. Great Britain adopted the same limits.

The US and EU do not even classify the product the same way. In the EU and UK a salicylic acid acne wash is a cosmetic. In the US it is an over-the-counter drug under the topical acne monograph at 0.5 to 2 percent - a monograph that never mentions pregnancy.

The NHS publishes nothing on cosmetic salicylic acid. NICE's acne guidance addresses clinical treatment, and its only comment on topical salicylic acid concerns limited evidence for efficacy rather than safety. The FDA's page on beta hydroxy acids does not mention pregnancy once, and Health Canada, FSANZ and the Australian chemicals regulator publish nothing either.

Where the advice to avoid large body areas in the third trimester comes from is worth knowing: it entered the literature through two secondary review articles, was picked up by the US ingredient review panel, then tested quantitatively by that same panel and rejected - its formal conclusion carries no pregnancy caveat and no body-area caveat.